Taru Deva

The Crystal Structure of Aminoglycoside-3′-Phosphotransferase-IIa, an Enzyme Responsible for Antibiotic Resistance

Didier Nurizzo, Steven C. Shewry, Michael H. Perlin et al. · Journal of Molecular Biology · 2003 · 108 citations

Crystal Structure, Enzyme Responsible, Antimicrobial Resistance Gene +8

Human Phenotypically Distinct TGFBI Corneal Dystrophies Are Linked to the Stability of the Fourth FAS1 Domain of TGFBIp

Kasper Runager, Rajiv Vaid Basaiawmoit, Taru Deva et al. · Journal of Biological Chemistry · 2010 · 63 citations · Full text

Protein Function, Signal Transduction, Ophthalmology +14

Structure of<i>Escherichia coli</i>UDP-<i>N</i>-acetylmuramoyl:<scp>L</scp>-alanine ligase (MurC)

Taru Deva, Edward N. Baker, C.J. Squire et al. · Acta Crystallographica Section D Biological Crystallography · 2006 · 38 citations

Early Stages of Amyloid Fibril Formation Studied by Liquid-State NMR: The Peptide Hormone Glucagon

Anna Sigrid Pii Svane, Kasper Jahn, Taru Deva et al. · Biophysical Journal · 2008 · 35 citations · Full text

Alzheimer's Disease, Early Stages, Biochemistry +8

Positive Allosteric Modulators of 2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid Receptors Belonging to 4-Cyclopropyl-3,4-dihydro-2<i>H</i>-1,2,4-pyridothiadiazine Dioxides and Diversely Chloro-Substituted 4-Cyclopropyl-3,4-dihydro-2<i>H</i>-1,2,4-benzothiadiazine 1,1-Dioxides

Pierre Francotte, Ann‒Beth Nørholm, Taru Deva et al. · Journal of Medicinal Chemistry · 2014 · 27 citations · Full text

Chemistry, Chemical Biology, Pharmaceutical Chemistry +17